Link to this page
Medical Subject Headings
Last uploaded:
March 22, 2026
| Id | http://purl.bioontology.org/ontology/MESH/C527479
http://purl.bioontology.org/ontology/MESH/C527479
|
|---|---|
| Preferred Name | JNJ-26076713 |
| Synonyms |
(3,S,beta,S)-1,2,3,4-tetrahydro-beta-((1-(1-oxo-3-(1,5,6,7-tetrahydro-1,8-naphthyridin-2-yl)propyl)-4-piperidinyl)methyl)-3-quinolinepropanoic acid
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| altLabel | (3,S,beta,S)-1,2,3,4-tetrahydro-beta-((1-(1-oxo-3-(1,5,6,7-tetrahydro-1,8-naphthyridin-2-yl)propyl)-4-piperidinyl)methyl)-3-quinolinepropanoic acid
|
|---|---|
| prefLabel | JNJ-26076713
|
| Scope Statement | a potent, orally bioavailable, nonpeptide alpha(V) integrin antagonist ; structure in first source
|
| type | |
| tui | T109
|
| HM |
D009287
D011804
|
| SC | 1
|
| TERMUI |
T716636
T716637
|
| TH | NLM (2008)
|
| SRC | J Pharmacol Exp Ther 2008 Mar;324(3):894-901
|
| MMR | 20080321
|
| notation | C527479
|
| Semantic type UMLS property | |
| cui |
C2352295
C2352296
|
| MeSH Frequency | 2
|
| DSC | 20080321
|
| Inverse of RB | 0
|
| Mapped to | |
| MDA | 20080321
|
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |